CareDx, Inc. — Investor Relations & Filings

CareDx, Inc. is a precision medicine company focused on the discovery, development, and commercialization of diagnostic solutions for organ transplant patients. The company provides a range of products and services that support patients and clinicians throughout the pre- and post-transplant journey. Its core offerings include non-invasive, genomics-based surveillance tests to monitor organ health and identify potential rejection. Key products include AlloSure, a donor-derived cell-free DNA (dd-cfDNA) test for assessing organ injury, and AlloSeq, a solution for high-resolution HLA typing. CareDx also offers digital health solutions, such as the AlloCare mobile app for patient management, and services like RemoTraC for remote sample collection, aiming to improve long-term transplant outcomes.